Last reviewed · How we verify
NCT05229575: BoMB
Breast Stereotactic Radiotherapy to Primary Tumors in Metastatic Patients
NA trial testing Stereotactic Body Radiation Therapy (SBRT) in Stage IV Breast Cancer in 30 participants. Status unknown.
10 October 2022
Quick facts
| Lead sponsor | Campus Bio-Medico University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 10 July 2020 |
| Primary completion | 10 October 2022 |
| Estimated completion | 10 April 2023 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Stereotactic Body Radiation Therapy (SBRT) — full drug profile →
Conditions studied
- Stage IV Breast Cancer — all drugs for Stage IV Breast Cancer →
Sponsor
Campus Bio-Medico University
Who can join
18 and older, female only, with Stage IV Breast Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a dose escalation study involving stage IV breast cancer patients not progressing after 6 months of first line systemic treatment. Potential advantages of stereotactic body radiotherapy (SBRT) in treating breast primary tumor in metastatic breast cancer are: * radio-biological advantage of a short highly effective treatment schedule * possibility of preventing lesions to become symptomatic * possibility of continuing systemic treatment without interruption
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
BOMB trial: First results of stereotactic radiotherapy to primary breast tumor in metastatic breast cancer patients.
Ippolito E, Silipigni S, Pantano F, Matteucci P, et al · · 2023 · cited 7× · PMID 37007063 · DOI 10.3389/fonc.2023.1062355
Verify or expand the search:
- PubMed search for NCT05229575
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Stereotactic Body Radiation Therapy (SBRT)
Trials testing the same drug.
- NCT07470840 — SBRT Plus Anlotinib and Bimepolizumab in Locally Advanced or Metastatic Renal Cell Carcinoma · Phase 2 · not yet recruiting
- NCT07346170 — Short Interval Postoperative Stereotactic Body Radiation Therapy (SBRT) After Surgical Intervention for Spine Metastases · NA · not yet recruiting
- NCT07258147 — Safety and Efficacy of Radiotherapy Combined With Immunochemotherapy in Pre-treated SCLC Patients With Liver Metastases · Phase 2 · not yet recruiting
- NCT07530172 — Radioembolization Versus External Radiation Therapy · Phase 2 · recruiting
- NCT06835725 — Phase II Randomized Trial of 2 Versus 5 Fraction Prostate Stereotactic Ablative Radiotherapy for Intermediate Risk Prost · Phase 2 · recruiting
Other recruiting trials for Stage IV Breast Cancer
Currently open trials in the same condition.
- NCT06678269 — A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer · Phase 1 · recruiting
- NCT06439693 — The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer · Phase 2 · recruiting
- NCT05959291 — Discontinuation of Maintenance HER-2 Directed Therapy in Long-Term Survivors of Metastatic HER-2 Positive Breast Cancer · NA · recruiting
- NCT03971409 — Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurre · Phase 2 · active not recruiting
- NCT06361264 — Clinical Study of Personalized Chemotherapy for Breast Cancer With Low Doses of Cyclophosphamide · EARLY_PHASE1 · recruiting
Other Campus Bio-Medico University trials
Trials by the same sponsor.
- NCT07448350 — TENS for Restoring Somatotopic Sensory Feedback in Lower Limb Amputees and Improving Phantom Limb Perception · NA · not yet recruiting
- NCT06860841 — Effects of D-Chiro-Inositol Combined with Metformin on Insulin Resistance in People with Overweight or Obesity and T2DM · Phase 4 · active not recruiting
- NCT06834269 — Transcranial Static Magnetic Stimulation (tSMS) and Potential Theranostic Biomarkers in Amyotrophic Lateral Sclerosis. · NA · recruiting
- NCT06098040 — Long-Term Feedback Effect of FGM in Newly-Diagnosed T2D Patients · NA · active not recruiting
- NCT05842148 — Quality of Life After Conservative Oncoplastic Surgery in Breast Cancer Patients (IRONY: lIfe afteR ONcoplastic surgerY) · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05229575 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Campus Bio-Medico University
- Last refreshed: 8 February 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05229575.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing